Agreed, but as said, there was the one thing I don't believe we knew, and that was the early DFU results. There was also much more emphasis on differentiating the IPSC process and batch consistency with Cymerus (for obvious recent contextual reasons) than past presentations and hopefully the company posts the presentation on their website (they usually do) and you can all have a look:
"Happy to be corrected, but there appeared to be some new information on the DFU trial with some early graphed results from that trial showing around 70-80% success rate in DFU treatment from early results vs around 40% in SOC on the quick glimpse of the graph we were given".
CYP Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)